Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Atara Biotherapeutics, Inc. (ATRA) had Cash Flow from Financial Activities of $16.10M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.59M |
|
$-3.41M |
|
$0.10M |
|
$1.49M |
|
$4.16M |
|
$-2.56M |
|
$-0.84M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-2.56M |
|
$-2.43M |
|
12.54M |
|
12.72M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$12.21M |
|
$0.07M |
|
$8.02M |
|
$20.23M |
|
$14.92M |
|
-- |
|
$43.81M |
|
$58.74M |
|
$-38.50M |
|
$-38.50M |
|
$-38.50M |
|
7.32M |
|
| Cash Flow Statement Financials | |
$-50.94M |
|
$18.15M |
|
|
Cash Flow from Financial Activities |
$16.10M |
$25.18M |
|
$8.48M |
|
$-16.69M |
|
$9.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.48% |
|
-160.69% |
|
-160.69% |
|
-- |
|
-213.54% |
|
-213.54% |
|
$-49.99M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
1.27 |
|
70.70 |
|
8.85% |
|
8.85% |
|
-16.83% |
|
8.85% |
|
$-5.26 |
|
$-3.93 |
|
$-4.01 |
|